Insider · CIK 0001365493
R Scott Huennekens
Files at NPCE (NeuroPace Inc), NVST (Envista Holdings Corp), QDEL (QuidelOrtho Corp). First filing -, latest -.
In brief
R Scott Huennekens files SEC Form 4 as director at NPCE (NeuroPace Inc), and also at NVST (Envista Holdings Corp), QDEL (QuidelOrtho Corp). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; R Scott Huennekens has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Equity Grant)derivative | +15,532 | $0.00 | $0 | 15,532 | Jun 29, 2026 |
| Jun 5, 2026 | NPCE NeuroPace Inc | AGrant or award Common Stock | +2,890 | $0.00 | $0 | 2,890 | Jun 5, 2026 |
| Jun 5, 2026 | NPCE NeuroPace Inc | AGrant or award Stock Option (Right to Buy)derivative | +5,368 | $0.00 | $0 | 5,368 | Jun 5, 2026 |
| May 29, 2026 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +6,829 | $0.00 | $0 | 9,352 | Jun 2, 2026 |
| May 29, 2026 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Equity Grant)derivative | -6,829 | $0.00 | $0 | 0 | Jun 2, 2026 |
| May 19, 2026 | NVST Envista Holdings Corp | AGrant or award Common Stock | +12,585 | $0.00 | $0 | 82,105 | May 21, 2026 |
| Jun 10, 2025 | NVST Envista Holdings Corp | AGrant or award Common Stock | +14,370 | $0.00 | $0 | 69,520 | Jun 12, 2025 |
| Jun 6, 2025 | NPCE NeuroPace Inc | AGrant or award Stock Option (right to buy)derivative | +8,745 | $0.00 | $0 | 8,745 | Jun 9, 2025 |
| May 29, 2025 | QDEL QuidelOrtho Corp | AGrant or award Restricted Stock Units (Equity Grant)derivative | +6,829 | $0.00 | $0 | 6,829 | Jun 2, 2025 |
| May 22, 2025 | QDEL QuidelOrtho Corp | AGrant or award Common Stock | +2,523 | $0.00 | $0 | 2,523 | May 27, 2025 |
| May 22, 2025 | QDEL QuidelOrtho Corp | MOption exercise Restricted Stock Units (Equity Grant)derivative | -2,523 | $0.00 | $0 | 0 | May 27, 2025 |
| Jan 6, 2025 | NPCE NeuroPace Inc | AGrant or award Stock Option (Right to Buy)derivative | +15,507 | $0.00 | $0 | 15,507 | Jan 8, 2025 |
Questions about R Scott Huennekens
Answered from the filings on this page, as of the latest one.
Is R Scott Huennekens buying or selling?
R Scott Huennekens has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did R Scott Huennekens's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and R Scott Huennekens has 0.
Where does R Scott Huennekens file Form 4?
R Scott Huennekens has filed Form 4 at NPCE (NeuroPace Inc); NVST (Envista Holdings Corp); QDEL (QuidelOrtho Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.